Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






![FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.](https://figures.cochat.ai/paper-figures/3022e35eb41542a6a28d8ac7db63b15b/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-3.png)



![FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).](https://figures.cochat.ai/paper-figures/b879709650c441a69692ab58e3270712/novel-docosatrienes-and-17s-resolvins-generated-from-docosahexaenoic-acid-in-figure-5.png)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [98]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Self-citationSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Self-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Self-citationMarchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationA NEW DEFICIENCY DISEASE PRODUCED BY THE RIGID EXCLUSION OF FAT FROM THE DIET
Burr, G. O., & Burr, M. M. (1929) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)78281-5 · Cited by 1,185
Gunstone, F. D., Harwood, J. L., & Padley, F. B. (1994) · Cited by 1,010
Mechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Research works printed but not linked: 8
- Gallin, J. I., and Snyderman, R. (eds) (1999) Inflammation: Basic Principles and Clinical Correlates, Lippincott Williams & Wilkins, Philadelphia
- Bergstro ¨m, S. (1982) in Les Prix Nobel: Nobel Prizes, Presentations, Biogra- phies and Lectures, pp. 129 -148, Almqvist & Wiksell, Stockholm
- De Caterina, R., Endres, S., Kristensen, S. D., and Schmidt, E. B. (eds) (1993) n-3 Fatty Acids and Vascular Disease, Springer-Verlag, London
- Gronert, K., Clish, C. B., Romano, M., and Serhan, C. N. (1999) in Eicosanoid Protocols (Lianos, E. A., ed) pp. 119 -144, Humana Press, Totowa, NJ 28.
- Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 285, 252-261
- Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S. (1990) in Biological Oxidation Systems Vol. 2, pp. 765-778, Academic Press
- Bazan, N. G. (1990) in Nutrition and the Brain (Wurtman, R. J., and Wurtman, J. J., eds) Vol. 8, pp. 1-22, Raven Press, New York
- Bazan, N. G., and Rodriguez de Turco, E. B. (2001) in Neuroprotection (Lo, E. H., and Marwoh, J., eds) pp. 195, Prominent Press
Cited by
Items 101–200 of 997
Resolvins and protectins: mediating solutions to inflammation
Kohli, P., & Levy, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00290.x · Cited by 292
“In the absence of aspirin, endogenous DHA substrate is enzymatically converted in vivo to 17S alcohol containing series of Rvs (RvD1-RvD4) (Figure 3B), and triene-containing structures via a LOX-mediated mechanism (Hong et al., 2003).”
BackgroundMethodResultInfluentialTranscriptomic analyses of murine resolution-phase macrophages
Stables, M. J., Shah, S., Camon, E. B., Lovering, R. C., Newson, J., Bystrom, J., Farrow, S., & Gilroy, D. W. (2011) · Blood · doi:10.1182/blood-2011-04-345330 · Cited by 291
Targeting inflammation in metabolic syndrome
Welty, F. K., Alfaddagh, A., & Elajami, T. K. (2016) · Translational Research · doi:10.1016/j.trsl.2015.06.017 · Cited by 287
DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
“, 2004) and in glial cells to block cytokine production (Hong et al., 2003).”
BackgroundInfluentialResolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Krishnamoorthy, S., Recchiuti, A., Chiang, N., Fredman, G., & Serhan, C. N. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.01.028 · Cited by 283
Self-citationNovel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
Self-citationOmega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ross, B. M., Seguin, J., & Sieswerda, L. E. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-21 · Cited by 275
Tissue n−3 and n−6 fatty acids and risk for coronary heart disease events
Harris, W. S., Poston, W. C., & Haddock, C. K. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.018 · Cited by 271
Marszalek, J. R., & Lodish, H. F. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120624 · Cited by 270
Weylandt, K. H., Chiu, C.-Y., Gomolka, B., Waechter, S. F., & Wiedenmann, B. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.005 · Cited by 258
Serhan, C. N. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.001 · Cited by 257
“In addition to the resolvins, protectins and maresins (Hong et al., 2003; Serhan et al., 2002), conjugates of the epoxide intermediates in each of the SPM pathways were uncovered in recent studies; these novel SPM-peptido conjugates enhance tissue regeneration and bacterial killing and clearance;…”
BackgroundSelf-citationBento, A. F., Claudino, R. F., Dutra, R. C., Marcon, R., & Calixto, J. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101305 · Cited by 256
“In addition, both 17R and 17S D series resolvins exhibit pronounced anti-inflammatory action in vivo (12, 13).”
BackgroundSapieha, P., Stahl, A., Chen, J., Seaward, M. R., Willett, K. L., Krah, N. M., Dennison, R. J., Connor, K. M., Aderman, C. M., Liclican, E., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001571 · Cited by 252
“Moreover, COX-2 modified by aspirin metabolizes EPA and DHA into bioactive epimers of resolvins (RvE1 and RvDs) and protectins (52, 54, 55) and would be expected to potentially further attenuate retinal neovascularization (5).”
BackgroundSelf-citationDifferential immunomodulation with long-chain n-3 PUFA in health and chronic disease
Sijben, J. W. C., & Calder, P. C. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s0029665107005472 · Cited by 249
“…mediators D-series resolvins, docosatrienes and neuroprotectins, also produced by cyclooxygenase-2 and lipoxygenase under some conditions, have been identified that also appear to be antiinflammatory and inflammation resolving (Hong et al. 2003; Marcheselli et al. 2003; Mukherjee et al. 2004).”
BackgroundBazan, N. G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r300013-jlr200 · Cited by 247
Ariel, A., Li, P.-L., Wang, W., Tang, W.-X., Fredman, G., Hong, S., Gotlinger, K. H., & Serhan, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509796200 · Cited by 246
Self-citationNew pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration
Serhan, C. N., Chiang, N., & Dalli, J. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.08.002 · Cited by 245
“We found that DHA is released from phosphatidylethanolamine in phagocytosis (Hong et al., 2003) and released substrate is converted to (Fig.”
BackgroundSelf-citationDumbleton, K., Caffery, B., Dogru, M., Hickson-Curran, S., Kern, J., Kojima, T., Morgan, P. B., Purslow, C., Robertson, D. M., & Nelson, J. D. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13125 · Cited by 245
Aging: An important factor for the pathogenesis of neurodegenerative diseases
Farooqui, T., & Farooqui, A. A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.11.006 · Cited by 245
“The action of a 15-lipoxygenase-like enzyme on docosahexaenoic acid produces 17S-resolvins, 10-17S-docosatrienes, and protectins (Hong et al., 2003; Marcheselli et al., 2003; Serhan and Savill, 2005) (Fig.”
BackgroundZhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243
“(American Research Products, Belmont, MA); IRDyeTM 700 or 800 infrared dye-labeled secondary antibodies (Rockland Immunochemicals, Gilbertsville, PA); FITC fluorescein conjugated secondary antibody (BD Biosciences, San Jose, CA); Cy3 fluorescein conjugated secondary antibody (GE Healthcare, Piscataway, NJ). Additional…”
MethodInfluentialPark, C.-K., Lü, N., Xu, Z.-Z., Liu, T., Serhan, C. N., & Ji, R.-R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2443-11.2011 · Cited by 241
“…D1 (NPD1) is biosynthesized from -3 fatty acid docosahexaenoic acid (DHA) and was first identified in resolving inflammatory exudates and murine brain (Serhan et al., 2002; Hong et al., 2003) as well as in experimental stroke, where it displays potent protective actions (Marcheselli et al., 2003).”
BackgroundSelf-citationAhmmed, M. K., Ahmmed, F., Tian, H. (., Carne, A., & Bekhit, A. E. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12510 · Cited by 241
Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution
Kasuga, K., Yang, R., Porter, T. F., Agrawal, N., Petasis, N. A., Irimia, D., Toner, M., & Serhan, C. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8677 · Cited by 239
“For example, DHA is esterified in phospholipids of microglial cells in culture and, on activation of these cells, DHA is released from the phospholipids for enzymatic processing (43, 44).”
BackgroundSelf-citationTargeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications
Aïd, S., & Bosetti, F. (2011) · Biochimie · doi:10.1016/j.biochi.2010.09.009 · Cited by 239
Lipid Signaling in Neural Plasticity, Brain Repair, and Neuroprotection
Bazan, N. G. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:1:089 · Cited by 236
Singer, P., Shapiro, H., Theilla, M., Anbar, R., Singer, J., & Cohen, J. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1142-4 · Cited by 232
“PD1 and RvD1 are produced ex vivo by human blood cells incubated with DHA [60, 61 ], in vivo in the human airways [62], as well as in the rodent brain [55, 61], liver [63] and kidney [64].”
BackgroundInfluentialFrisardi, V., Panza, F., Seripa, D., Farooqui, T., & Farooqui, A. A. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.001 · Cited by 229
Neuhofer, A., Zeyda, M., Mascher, D., Itariu, B. K., Murano, I., Leitner, L., Hochbrugger, E. E., Fraisl, P., Cinti, S., Serhan, C. N., et al. (2013) · Diabetes · doi:10.2337/db12-0828 · Cited by 229
“We show here that the adipose tissue level of 12/15-LOX mRNA, a pivotal enzyme for 17-HDHA and PD1 biosynthesis in mice (37,38), is significantly decreased in dietinduced obesity, corroborating previous data that impaired 12/15-LOX activity results in a resolution-deficient phenotype (39–41).”
BackgroundSelf-citationNovel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins
Serhan, C. N. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200503000-00003 · Cited by 227
Self-citationSansbury, B. E., & Spite, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.307308 · Cited by 226
González‐Périz, A., Planagumà, A., Gronert, K., Miquel, R., López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., Deulofeu, R., Arroyo, V., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6250fje · Cited by 225
“In addition, both PD1 and 17S-HDHA potently inhibit TNFinduced IL-1 gene expression in human microglial cells ( 4 ).”
BackgroundMethodInfluentialSelf-citationDiscovery of essential fatty acids
Spector, A. A., & Kim, H.-Y. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r055095 · Cited by 218
Novel Metabolism of Docosahexaenoic Acid in Neural Cells
Kim, H.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700015200 · Cited by 219
Effects of Lithium on Inflammation
Nassar, A., & Azab, A. N. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500038f · Cited by 219
McGlory, C., Calder, P. C., & Nunes, E. A. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00144 · Cited by 218
Oxidative stress and antioxidants: Distress or eustress?
Niki, E. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.017 · Cited by 209
Lima-Garcia, J., Dutra, R., da Silva, K., Motta, E., Campos, M., & Calixto, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01345.x · Cited by 209
“However, we cannot rule out the possible conversion of the precursor 17(R)HDoHE to other 17R-RvD series, because previous studies have suggested that this precursor could generate different aspirin-triggered resolvins (Serhan et al., 2000; 2002; Hong et al., 2003).”
BackgroundResultInfluentialModulation of Inflammatory Cytokines by Omega-3 Fatty Acids
Kang, J. X., & Weylandt, K. H. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_5 · Cited by 208
“The protective effect of the DHA-derived lipid mediators has been examined in the model of ischemic brain injury, showing a significant neuroprotective effect by inhibition of NFkB activity, leukocyte migration and COX-2 induction (Hong et al., 2003).”
BackgroundLipoxins and new lipid mediators in the resolution of inflammation
SCHWAB, J., & SERHAN, C. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.006 · Cited by 207
Self-citationZúñiga, J., Cancino, M., Medina, F., Varela, P., Vargas, R., Tapia, G., Videla, L. A., & Fernández, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028502 · Cited by 206
Carcinogenesis: Failure of resolution of inflammation?
Fishbein, A., Hammock, B. D., Serhan, C. N., & Panigrahy, D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107670 · Cited by 205
Self-citationPro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204
“However, levels of RvD5, MaR1, and protectin D1 (PD1), all derived from DHA, were lower in the AD group than in the control group (Fig.”
InfluentialSelf-citationEl‐Sharkawy, H., Aboelsaad, N., Eliwa, M., Darweesh, M., Alshahat, M., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.090628 · Cited by 203
Inflammation and its genesis in cystic fibrosis
Nichols, D. P., & Chmiel, J. F. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23242 · Cited by 202
“DHA is a precursor of several of these anti-inflammatory lipids.(179) Lipoxins are enzymatically generated from omega-6 polyunsaturated fatty acids.”
BackgroundOral infections and cardiovascular disease
Kholy, K. E., Genco, R. J., & Van Dyke, T. E. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.03.001 · Cited by 197
Review of Eukaryote Cellular Membrane Lipid Composition, with Special Attention to the Fatty Acids
Ali, O., & Szabó, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115693 · Cited by 191
DeMar, J. C., Ma, K., Bell, J. M., & Rapoport, S. I. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02789.x · Cited by 194
“The specificities of PLA2 and COX-2 have not been tested for DPAn-6, but in general, these enzymes appear to have high selectivity for PUFAs in the range of C20 to C22, with 4–6 double bonds (Diez et al. 1992; Ringbom et al. 2001; Strokin et al. 2003).”
BackgroundInfluentialLee, S. H., Williams, M. V., DuBois, R. N., & Blair, I. A. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1170 · Cited by 192
The role of eicosanoids in the brain.
Tassoni, D., Kaur, G., Weisinger, R. S., & Sinclair, A. J. (2008) · PubMed · Cited by 229
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Devassy, J. G., Leng, S., Gabbs, M., Monirujjaman, M., & Aukema, H. M. (2016) · Advances in Nutrition · doi:10.3945/an.116.012187 · Cited by 183
Lipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“Moreover, PD1 exhibits tissue-specific bioactivity as in humans this lipid is synthesised by peripheral blood mononuclear cells and Th2 CD4+ T-cells, while in mice it has been isolated from exudates and brain cells, human microglial cells (111) and in peripheral blood (108).”
BackgroundInfluentialThe Biosynthesis of Enzymatically Oxidized Lipids
Hajeyah, A. A., Griffiths, W. J., Wang, Y., Finch, A. J., & O’Donnell, V. B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.591819 · Cited by 180
“The former two are important in the biosynthesis of leukotrienes, while the latter two are proposed to be precursors of E- and D-series resolvins, respectively (75, 80).”
BackgroundNovel ? ? 3-derived local mediators in anti-inflammation and resolution
NSERHAN, C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.09.002 · Cited by 181
Resolvin D1 protects mice from LPS-induced acute lung injury
Wang, B., Gong, X., Wan, J.-Y., Zhang, L., Zhang, Z., Li, H.-Z., & Min, S. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.04.001 · Cited by 178
Patel, J. P., & Frey, B. N. (2015) · Neural Plasticity · doi:10.1155/2015/708306 · Cited by 177
“which possesses known anti-inflammatory properties [127, 128].”
Mechanisms of Resolution of Inflammation: A Focus on Cardiovascular Disease
Maskrey, B. H., Megson, I. L., Whitfield, P. D., & Rossi, A. G. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213850 · Cited by 177
New Insights Regarding the Autoxidation of Polyunsaturated Fatty Acids
Yin, H., & Porter, N. A. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.170 · Cited by 177
“These two PUFAs are rich in fish oil, and extensive research has been carried out to understand the beneficial effects of fish oil (9, 27, 50, 54, 68, 79, 92).”
Bang, S., Yoo, S., Yang, T., Cho, H., Kim, Y., & Hwang, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00909.x · Cited by 176
“Serhan’s group were the first to report that the D-series of resolvins were generated by the 15- and 5-lipoxygenases from docosahexanoic acid and released from tissues (Serhan et al., 2002; Hong et al., 2003).”
BackgroundSerhan, C. N. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0695-8 · Cited by 175
“…2000) or autooxidized to products that are monohydroxy racemates (VanRollins et al. 1984) of the compounds that are now known to be enzymatically produced during biosynthesis of the resolvins and docosatrienes (Serhan et al. 2002; Hong et al. 2003; Marcheselli et al. 2003; Mukherjee et al. 2004).”
BackgroundMethodInfluentialSelf-citationOmega 3 fatty acids and the brain: review of studies in depression.
Sinclair, A. J., Begg, D. P., Mathai, M. L., & Weisinger, R. S. (2007) · PubMed · Cited by 216
Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma
Aoki, H., Hisada, T., Ishizuka, T., Utsugi, M., Kawata, T., Shimizu, Y., Okajima, F., Dobashi, K., & Mori, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.012 · Cited by 173
The Role of Neutrophils and Monocytes in Innate Immunity
Kantari, C., Pederzoli-Ribeil, M., & Witko-Sarsat, V. (2008) · Contributions to Microbiology · doi:10.1159/000136335 · Cited by 169
The two faces of the 15-lipoxygenase in atherosclerosis
Wittwer, J., & Hersberger, M. (2007) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.08.001 · Cited by 168
SERHAN, C. N. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03396.x · Cited by 166
Self-citationNovel Proresolving Aspirin-Triggered DHA Pathway
Serhan, C. N., Fredman, G., Yang, R., Karamnov, S., Belayev, L. S., Bazan, N. G., Zhu, M., Winkler, J. W., & Petasis, N. A. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.008 · Cited by 164
“In the biosynthesis of protectins, two endogenous forms of the pathway exist, namely the aspirin-dependent as documented here, and the lipoxygenase-initiated pathway for NPD1/PD1 (Bazan, 2006; Bazan et al., 2010; Hong et al., 2003; Mukherjee et al., 2004; Serhan et al., 2002).”
InfluentialSelf-citationMarkworth, J. F., Vella, L., Lingard, B. S., Tull, D. L., Rupasinghe, T. W., Sinclair, A. J., Maddipati, K. R., & Cameron-Smith, D. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00128.2013 · Cited by 163
“81 and 86), including the AA-derived lipoxins (LXs) (54, 93, 94), and the eicosapentaenoic (EPA) (E-series)/docosahexaenoic acid (DHA) (D-series)-derived resolvins (Rv) (83, 85) and protectins (P) (42, 84).”
Unesterified docosahexaenoic acid is protective in neuroinflammation
Orr, S. K., Palumbo, S., Bosetti, F., Mount, H. T., Kang, J. X., Greenwood, C. E., Ma, D. W. L., Serhan, C. N., & Bazinet, R. P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12392 · Cited by 163
“Novel families of bioactive lipid mediators were recently identified and characterized (Hong et al. 2003; Serhan et al. 2008, 2012).”
BackgroundSelf-citationOmega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs
Im, D.-S. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.02.003 · Cited by 162
Fredman, G., & Serhan, C. N. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00984-x · Cited by 186
Self-citationGiacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
“by studies using brain tissue homogenates (30, 31), neuron-glia cultures or hippocampal tissue (32).”
Methodn−3 Fatty acids, inflammation, and immunity— Relevance to postsurgical and critically III patients
Calder, P. C. (2004) · Lipids · doi:10.1007/s11745-004-1342-z · Cited by 159
Fredman, G., & Serhan, C. N. (2011) · Biochemical Journal · doi:10.1042/bj20110327 · Cited by 158
Self-citationLipidomics of oxidized polyunsaturated fatty acids
Massey, K. A., & Nicolaou, A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.565 · Cited by 186
Hasegawa, T., Hall, C. J., Crosier, P. S., Abe, G., Kawakami, K., Kudo, A., & Kawakami, A. (2017) · eLife · doi:10.7554/elife.22716 · Cited by 156
Nutrition and human health from a sex–gender perspective
Marino, M., Masella, R., Bulzomi, P., Campesi, I., Malorni, W., & Franconi, F. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.02.001 · Cited by 175
“The eicosanoids derived from EPA are less inflammatory or even anti-inflammatory compared to eicosanoids derived from arachidonic acid; DHA can be metabolized to resolvins via LOX-initiated mechanisms (Hong et al., 2003; Radmark and Samuelsson, 2010; Serhan et al., 2000; Serhan et al., 2002).”
BackgroundKetogenic diet and Neuroinflammation
Koh, S., Dupuis, N., & Auvin, S. (2020) · Epilepsy Research · doi:10.1016/j.eplepsyres.2020.106454 · Cited by 177
Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro
Rey, C., Nadjar, A., Buaud, B., Vaysse, C., Aubert, A., Pallet, V., Layé, S., & Joffre, C. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.013 · Cited by 176
Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases
Li, X., Bi, X., Wang, S., Zhang, Z., Li, F., & Zhao, A. Z. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02241 · Cited by 179
de Roos, B., Mavrommatis, Y., & Brouwer, I. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00189.x · Cited by 151
“Although there are a number of protectin isomers derived from DHA, protectin D1 is the most potent isomer and it is biosynthesized via a LOX-mediated pathway (Hong et al., 2003).”
InfluentialHost persistence: exploitation of anti-inflammatory pathways by Toxoplasma GONDII
Aliberti, J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1547 · Cited by 182
“Also, other recently identified classes of anti-inflammatory mediator — such as those derived from docosahexaenoic acid (DHA), which are known as the resolvins (resolution-phase interaction products) — also seem to depend on 5-lipoxygenase-like activit”
BackgroundRecchiuti, A., & Serhan, C. N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00298 · Cited by 149
“…, because they: (a) are produced during cell–cell interactions occurring in the resolution phase of acute inflammatory response; (b) “stop” further neutrophil entry to sites of inflammation, and (c) reduce exudates (Serhan et al., 2000a, 2002, 2006; Hong et al., 2003; Bannen-berg et al., 2005).”
BackgroundInfluentialSelf-citationFarina, E. K., Kiel, D. P., Roubenoff, R., Schaefer, E. J., Cupples, L. A., & Tucker, K. L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005926 · Cited by 156
Lipoxins: endogenous regulators of inflammation
McMahon, B., & Godson, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2003 · Cited by 148
“Aspirin therapy can lead to the generation of the 17(R)resolvins from DHA (57, 108).”
BackgroundInfluentialN-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation
Joffre, C., Rey, C., & Layé, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01022 · Cited by 147
Maksymowych, W. P., Wichuk, S. A., Chiowchanwisawakit, P., Lambert, R. G. W., & Pedersen, S. J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38792 · Cited by 149
Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice
Yamada, T., Tani, Y., Nakanishi, H., Taguchi, R., Arita, M., & Arai, H. (2011) · The FASEB Journal · doi:10.1096/fj.10-170027 · Cited by 143
“The DHAderived lipid mediator PD1 is biosynthesized via a 12/15-LOX-mediated pathway that converts DHA into a 10,17-dihydroxy-containing bioactive molecule (17, 19).”
BackgroundColombo, S. M., Wacker, A., Parrish, C. C., Kainz, M. J., & Arts, M. T. (2016) · Environmental Reviews · doi:10.1139/er-2016-0062 · Cited by 168
“DHA is directly involved in several processes in the brain including neurotransmission, cell survival, and prevents neuro-inflammation (and thereby mood and cognition, Bazinet and Layé 2014), and also acts as a precursor for docosatrienes, involved in anti-inflammation (Hong et al. 2003).”
BackgroundNeuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma
Xu, Z., Liu, X., Berta, T., Park, C., Lü, N., Serhan, C. N., & Ji, R. (2013) · Annals of Neurology · doi:10.1002/ana.23928 · Cited by 141
Self-citationRitchie, S. A., Ahiahonu, P. W. K., Jayasinghe, D., Heath, D., Liu, J., Lu, Y., Jin, W., Kavianpour, A., Yamazaki, Y., Khan, A. M., et al. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-13 · Cited by 142
Bazan, N. G., Calandria, J. M., & Serhan, C. N. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r001131 · Cited by 140
Self-citationHammock, B. D., Wang, W., Gilligan, M. M., & Panigrahy, D. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.06.010 · Cited by 160
Masoodi, M., Mir, A. A., Petasis, N. A., Serhan, C. N., & Nicolaou, A. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3331 · Cited by 139
Self-citationFish Oil for the Treatment of Cardiovascular Disease
Weitz, D., Weintraub, H., Fisher, E., & Schwartzbard, A. Z. (2010) · Cardiology in Review · doi:10.1097/crd.0b013e3181ea0de0 · Cited by 138
Poorani, R., Bhatt, A. N., Dwarakanath, B. S. R., & Das, U. N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.049 · Cited by 149
Neutrophil Development, Migration, and Function in Teleost Fish
Havixbeck, J. J., & Barreda, D. R. (2015) · Biology · doi:10.3390/biology4040715 · Cited by 163
“In another study, Gomez-Abellan and colleagues further showed that PGD(2) and its metabolites contribute to anti-inflammatory responses in the gilthead seabream [106].”
BackgroundDysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma
Miyata, J., Fukunaga, K., Iwamoto, R., Isobe, Y., Niimi, K., Takamiya, R., Takihara, T., Tomomatsu, K., Suzuki, Y., Oguma, T., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.048 · Cited by 136
Polyunsaturated fatty acids and epilepsy
Taha, A. Y., Burnham, W. M., & Auvin, S. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02654.x · Cited by 146
“2005, 2009), (5) synthesis of biologically active oxygenated derivatives (Zeldin, 2001; Hong et al., 2003; Farias et al., 2008), and (6) nuclear-receptor–mediated transcription of genes (Lin et al.”
BackgroundInfluentialMiyahara, T., Runge, S., Chatterjee, A., Chen, M., Mottola, G., Fitzgerald, J. M., Serhan, C. N., & Conte, M. S. (2013) · The FASEB Journal · doi:10.1096/fj.12-225615 · Cited by 134
Self-citationNon-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids
de Castro, G. S., & Calder, P. C. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.01.006 · Cited by 142
“Furthermore, EPA and DHA can be used by COX and LOX 517 enzymes to generate anti-inflammatory and inflammation resolving compounds including resolvins, 518 protectins and maresins [120-123].”
Background
Metadata
- Authors
- Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-04
- Volume
- 278
- Issue
- 17
- Pages
- 14677-14687
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2082649626
- Cited by
- 1,000
- References
- 53
- Citations by year
- 2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
- FWCI
- 34.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6388 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
- MeSH terms
- Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.